引航生物递表港交所

Group 1 - The core viewpoint of the article is that Suzhou Leadsynbio Technology Co., Ltd. has submitted an application for listing on the Hong Kong Stock Exchange, with Huatai International as its sole sponsor [1] - The company is positioned as a leader in synthetic biology driven by technological innovation, focusing on providing green, sustainable, and cost-effective bio-based products [1] - The company has achieved a significant market presence, holding a 24.5% market share in the global florfenicol industry, ranking second, and a 44.5% market share in the global D-ethyl market, ranking first, based on revenue for the nine months ending September 30, 2025 [1]